Mylan – Recall of insulin glargine
July 6, 2022, - The FDA announced a voluntary consumer-level recall of one lot of Mylan's (a Viatris company) interchangeable biosimilar insulin glargine (insulin glargine-yfgn) prefilled pens because of the potential for the label to be missing on some pens.
Download PDF
